LataMed AI Corp. (OTC: LMED), a healthcare technology company focused on Latin America, announced on July 31, 2026, that its Venezuelan subsidiary, LATAMEDAI VE, has entered into an agreement with the Venezuelan Institute for Scientific Research (IVIC) to develop a digital platform module. The module is designed to support access to designated laboratory and scientific services, marking a strategic move to extend the company's technology beyond patient-facing telemedicine into institutional and enterprise workflows.
Under the agreement, LataMed AI and IVIC will collaborate on the design, development, testing, and implementation of a digital interface that enables authorized business and institutional users to request available laboratory services, schedule appointments, monitor the status of submitted requests, access approved reports and documentation, and complete authorized payment-related processes. The proposed module aims to provide a centralized digital workflow for organizations seeking scientific and laboratory services in sectors such as healthcare, pharmaceuticals, food production, agriculture, and related industries. The specific services made available will be determined by IVIC and implemented according to technical, operational, security, and legal requirements established by both parties.
The companies will begin by defining the module's functional requirements, user-access procedures, data architecture, payment workflows, document-management capabilities, and a phased testing and implementation process. They will also establish procedures for handling, transmitting, storing, and granting authorized access to laboratory-related information and documentation. The platform's contemplated functionality includes electronic service requests, appointment scheduling, request-status tracking, secure payment facilitation, and controlled access to laboratory reports.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated, "This agreement represents an opportunity to apply our technology to an important area of scientific and enterprise service delivery. Our objective is to work with IVIC to develop a responsible digital framework that makes it easier for authorized users to request services, manage appointments, monitor processes, and access approved information through a centralized platform."
Management believes the proposed module could expand LataMed AI's capabilities beyond its current telemedicine focus, demonstrating how its technology can support institutional workflows involving healthcare, scientific services, laboratory coordination, and digital documentation. This initiative aligns with the company's broader strategy of developing digital infrastructure that connects patients, healthcare professionals, pharmacies, insurers, payment providers, wellness organizations, institutions, and other participants in the healthcare and scientific-services ecosystem.
If successfully implemented, the module could potentially be adapted for other institutional and enterprise service environments in Venezuela and elsewhere in Latin America. However, any future expansion would be subject to separate agreements, technical readiness, applicable regulatory requirements, and the needs of participating institutions. The agreement establishes the framework for development and evaluation but does not guarantee a specific implementation date, user adoption level, service volume, revenue, profitability, or expansion to additional institutions.
The announcement underscores the growing trend of integrating digital solutions into scientific and laboratory services, which could streamline operations and improve access for businesses and institutions. For LataMed AI, this partnership represents a significant step in diversifying its offerings and establishing a presence in the enterprise sector. The company will provide further updates as development and testing progress.
For more information, visit the company's website at https://latamed.ai or review its filings with the U.S. Securities and Exchange Commission at www.sec.gov.
